Medindia

X

Cardinal Health Declares Regular Quarterly Dividend

Thursday, August 5, 2010 Heart Disease News J E 4
Advertisement


DUBLIN, Ohio, Aug. 4 Cardinal Health today announced that its board of directors has approved a regular quarterly dividend of $0.195 per share, payable on Oct. 15 to shareholders of record on Oct. 1.

This marks the 104th consecutive regular quarterly dividend for Cardinal Health. The company had approximately 352 million shares outstanding as of July 31.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $96 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while reducing costs, improving efficiency and quality, and increasing profitability. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 60,000 locations each day. The company is also a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #17 on the Fortune 500, Cardinal Health employs more than 30,000 people worldwide. More information about the company may be found at cardinalhealth.com.

SOURCE Cardinal Health
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Onyx Pharmaceuticals Reports Second Quarter 2010 F...
S
Acquisition of Certain Cellumen Assets by Apredica